Carl Sailer, Director at Acurx Pharmaceuticals, Inc. (ACXP), bought 24,631 shares at $1.02 ($25K) on 2025-01-06, disclosed to the SEC on 2025-01-08.
Open-market purchase of $25k ACXP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ACXP | BUY | 2021-09-10 | $75K | — | Filing → |